Nalaganje...
Promising New Agents for Colorectal Cancer
There are many exciting new therapies being developed for mCRC patients. Beyond adding to existing combination backbones of chemotherapy with oxaliplatin and irinotecan, subsets of mCRC patients have been identified who may benefit from novel treatments such as immune checkpoint blockade, HER2 inhib...
Shranjeno v:
| izdano v: | Curr Treat Options Oncol |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2018
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6499928/ https://ncbi.nlm.nih.gov/pubmed/29752549 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11864-018-0543-z |
| Oznake: |
Označite
Brez oznak, prvi označite!
|